# Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

> **NCT04022616** · — · RECRUITING · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 99 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Specimen collection

## Key facts

- **NCT ID:** NCT04022616
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2010-06-04
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 99 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04022616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04022616, "Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04022616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*